Pemetrexed Baxter Uni Eropa - Bulgar - EMA (European Medicines Agency)

pemetrexed baxter

baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - Антинеопластични средства - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.

Endoxan 200 mg powder for solution for injection Bulgaria - Bulgar - Изпълнителна агенция по лекарствата

endoxan 200 mg powder for solution for injection

baxter oncology gmbh. - Циклофосфамид - 200 mg powder for solution for injection

Endoxan 500 mg powder for solution for injection Bulgaria - Bulgar - Изпълнителна агенция по лекарствата

endoxan 500 mg powder for solution for injection

baxter oncology gmbh. - Циклофосфамид - 500 mg powder for solution for injection